AGWCA
PBH icon

Annis Gardner Whiting Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-195
Closed -$15.6K – 1374
2025
Q2 		$15.6K Buy
+195
New +$16.3K 0.01% 610

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's PBH Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 195 shares — an estimated $15.6K sold.

Annis Gardner Whiting Capital Advisors first reported a position in PBH in Q2 2025 and held it in 1 quarter. The position peaked at $15.6K in Q2 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 195 Prestige Consumer Healthcare shares in Q3 2025, an estimated $15.6K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Prestige Consumer Healthcare in Q2 2025 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's Prestige Consumer Healthcare position peaked at $15.6K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.